Mucosally targeted protein

This chapter first provides a description of immunity in general and then more specifically, immunity in the mucosal immune system. The immune response of both intestinal and respiratory tracts will be described in detail as these are the two most common portals of targeted vaccine development for mucosal immunity. The chapter will cover the basis of mucosal immunity using plant-based oral vaccines. Strategies for increasing mucosal immunity, such as the use of adjuvants, will also be discussed. Finally, the chapter will cover the precliiucal tests and various cliiucal trials that are taking place with respect to production of human and veterinary therapeutic proteins in plants. 

In the intestinal mucosal cells, /3-carotene is cleaved via an oxygenase (an enzyme that introduces molecular 02 into organic compounds) to frans-retinal (aldehyde form of trans-retinol, as shown in Table 6.2), which in turn is reduced to frans-retinol, vitamin Av Retinol is then esterified with a fatty acid, becomes incorporated into chylomicrons, and eventually enters the liver, where it is stored in the ester form until it is required elsewhere in the organism. The ester is then hydrolyzed, and vitamin Ax is transported to its target tissue bound to retinol-binding protein (RBP). Since RBP has a molecular weight of only 20,000 and would be easily cleared by the kidneys, it is associated in the bloodstream with another plasma protein, prealbumin. 

The toxicity of formaldehyde is route-dependent. Irritation at the point of contact is seen by inhalation, oral, and dermal routes. High doses are cytotoxic and result in degeneration and necrosis of mucosal and epithelial cell layers. These observations are consistent with the hypothesis that toxic effects are mediated by formaldehyde itself and not by metabolites. No specific target molecule has been identified, although DNA-protein cross links have been identified (Casanova and Heck 1987). As discussed in... 

The capacity of pathogenic bacteria to adhere to mucosal membranes has been exploited in the modification of new mucoadhesive polymers. The ability of bacteria to adhere to a specific target is rooted from particular cell-surface components or appendages, known as fimbriae, which promote adhesion to other cells or inanimate surfaces. Fimbriae are extracellular, long thread-like protein polymers of bacteria that play a major role in many diseases. It has been reported that Escherichia coli adheres specifically to the lymphoid follicle epithelium of the ileal Peyer s patch in rabbits. Similarly, different staphylococci possess the ability to adhere specifically to the surface of mucus gel layers and not mucus-free surfaces. Thus, polymers have been modified by the attachment of these fimbriae to enhance mucoadhesion. An attachment protein derived from E. coli, K99-fimbriae, has been covalently attached to polyacrylic acid networks in an attempt to provide a novel polymer with enhanced adhesive properties (Figure 52.7). ... 

---